FILE PHOTO: Pens for the diabetes drug Ozempic sit on a production line to be packaged at the Danish drugmaker Novo Nordisk's site in Hillerod, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo

Home » News » Business & Economy » Canada approves second generic version of Ozempic

Business & Economy

Canada approves second generic version of Ozempic

by ReutersMay 1, 2026

OTTAWA, May 1 (Reuters) – The Canadian health regulator said on Friday that it had approved Canada-based Apotex’s generic version of semaglutide, making it the second copycat version of Danish drugmaker Novo Nordisk’s blockbuster diabetes drug Ozempic authorized in the country.

(Reporting by Ismail Shakil and Ryan Patrick Jones; Editing by Caitlin Webber)

Join the discussion → Share your thoughts!

Read more from our local writers → Candidate for Port Huron City Council - Gregg DeVoogd

Here's the winner of Rockford Register Star's Athlete of the Week poll

Reuters

Information you can trust. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. (c) 2025 Thomson Reuters

Candidate for Port Huron City Council – Gregg DeVoogd

Transforming Lives – Patrick Coughlin

Time to Lead – Jeffery Vega

Blessing of the Bikes – Gene Warren

Payton Reprimands Freed

Got LifeWise Academy? – Jayvon Moncrief

The Great Shaking in Port Huron – Gene Warren

Stop Human Trafficking – Angela Dudley

Manke v Shoudy – Crystal Manke

Michigan Recall Law – Paul Urben

Canada approves second generic version of Ozempic

Reuters

Leave a Comment Cancel Reply

Related posts

Leave a Comment Cancel Reply